Ensysce Biosciences's total assets for Q4 2023 were $2.71M, a decrease of -15.86% from the previous quarter. ENSC total liabilities were $3.36M for the fiscal quarter, a 63.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.